It takes less than a quarter of an hour for Silent Pandemic to give up on the pharmaceutical
industry. First we hear from Ella Balasa, a 29-year-old American who is finding it
increasingly difficult to overcome the bacterial infections related to her cystic
fibrosis. She faces the frightening prospect that what is now difficult will soon
become impossible. We then cross the Atlantic for an interview with Sally Davies,
UK Special Envoy on Antimicrobial Resistance, who notes that there is a lag of at
least 10 years between the identification of an actionable target and the entry into
the market of a drug aimed at the target.